Canada approves first bivalent Covid-19 booster for children aged 5-11 - Ottawa News
by IANS | Updated Dec 10, 2022
This is the first bivalent Covid-19 booster authorised for use in this age group that targets the original Covid-19 strain and the Omicron BA.4/BA.5 subvariants, Health Canada said in a statement on Friday.
According to the statement, Health Canada previously authorised this bivalent booster for use in individuals aged 12 years and older on October 7, 2022. While the formulation for children aged between 5 to 11 years is the same, the dose is one-third of that authorised for individuals aged 12 years and older.
The statement added that after a thorough and independent scientific review of the evidence, Health Canada has determined that the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent-adapted booster vaccine for children aged between 5 to 11 years is safe and effective and that its benefits outweigh any potential risks, Xinhua news agency reported.
Vaccination continues to be one of the most effective tools to protect families and communities against Covid-19, Health Canada said.
- 2 missing after cargo ships collide off western Japan
- Pakistan's forex reserves barely enough to provide import cover for 18.5 days
- Pakistan facing balance of payments crisis
- Pakistani rupee plunges to historic low
- Police in Khyber Pakhtunkhwa take to the streets against Peshawar suicide bombing
- Philippines' debt eased to $248.73bn by 2022 end
- Sacred rocks from Nepal to build Ram statue in Ayodhya handed over
- Japan's crime rate increases for 1st time in 20 years
- Peshawar mosque bomber was in police uniform
- New Zealand govt provides more support to flood-hit regions